654074-97-2Relevant articles and documents
4-Methyl-1,2,4-triazol-3-yl heterocycle as an alternative to the 1-methylimidazol-5-yl moiety in the Farnesyltransferase inhibitor ZARNESTRA
Angibaud, Patrick,Saha, Ashis K.,Bourdrez, Xavier,End, David W.,Freyne, Eddy,Lezouret, Patricia,Mannens, Geert,Mevellec, Laurence,Meyer, Christophe,Pilatte, Isabelle,Poncelet, Virginie,Roux, Bruno,Smets, Gerda,Van Dun, Jacky,Venet, Marc,Wouters, Walter
, p. 4361 - 4364 (2007/10/03)
Replacement of the 1-methylimidazol-5-yl moiety in the farnesyltransferase inhibitor ZARNESTRA series by a 4-methyl-1,2,4-triazol-3-yl group gave us compounds with similar structure-activity relationship profiles showing that this triazole is potentially a good surrogate to imidazole for farnesyltransferase inhibition.